...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZEN-3694 mCRPC Trial Status
6
Oct 24, 2017 11:18AM
1
Oct 25, 2017 09:02AM
2
Oct 26, 2017 10:24AM
5
Oct 26, 2017 12:13PM

Toniv,

Look back at Masila's unofficial transcript from the Jan 2016 Zenith AGM....in particular the Q&A session. He addressed many of your recent concerns there.....however, it will be great to revisit these topics at the 2017 AGM on Dec 12 to hear what DM's current thinking is on this.

BearDownAZ


Nov 02, 2017 03:38PM

Nov 02, 2017 04:29PM

Nov 03, 2017 10:49AM

Nov 03, 2017 10:58AM

Nov 03, 2017 12:07PM
2
Nov 03, 2017 03:45PM
2
Nov 03, 2017 04:23PM
5
Nov 18, 2017 07:45PM
Share
New Message
Please login to post a reply